
OncoSil
OSL.AXOncoSil Medical Limited Price (OSL.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
2,219,392,243
(85.5617)%Description
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorpora... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.004-0.015
- Market Cap 23.03M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Devices
- ceo: Mr. Nigel Lange
- IPO Date: August, 15, 2005
- Country: AU
- Currency: AUD
- Headquaters: North Sydney, NSW
- Employees: 2
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
